Clinical trial
A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
NCT01478438 is registered in ClinicalTrials.gov with Novian Health Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers
- Lead sponsor
- Novian Health Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2012
- Completion date
- August 31, 2021
- Enrollment
- 60 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
malignant tumor